United States

Back to map

Showing 271-280 of 327 grants

Title Institution Researcher Program Duration Total Award Amount
Effectiveness and safety of sotagliflozin in slowing kidney function decline in persons with type 1 diabetes and moderate to severe diabetic kidney disease: The SUGARNSALT Trial Joslin Diabetes Center Inc. Alessandro Doria Improving Lives 01-January-2024 to 31-December-2028 $8.913.450,00
Reducing Glycemic Variability to Improve Cardiovascular Health in Type 1 Diabetes Rector & Visitors of the University of Virginia William Horton Improving Lives 01-December-2022 to 30-November-2025 $858.072,00
Preclinical evaluation of SERCA2 activators for pancreatic beta-cell protection in T1D Neurodon LLC Russell Dahl Cures 01-June-2022 to 31-May-2026 $920.000,00
Developing fusion therapeutics to selectively target beta cell surface receptors for treating T1D UT Southwestern Wen-hong Li Cures 01-July-2022 to 30-June-2025 $900.000,00
Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial University of California, San Diego Charles Ginsberg Improving Lives 01-November-2022 to 31-October-2026 $1.356.726,45
Harnessing zinc-tropic agents for targeted delivery of therapeutics to islet beta cells for preventing or treating T1D UT Southwestern Wen-hong Li Cures 01-August-2022 to 31-October-2025 $900.000,00
Novel mechanism and method to control T cell mediated autoimmunity in type 1 diabetes Case Western Reserve University Parameswaran Ramakrishnan Cures 01-June-2022 to 31-May-2026 $600.000,00
Evaluating the dose and toxicity of telaprevir in a rat model of T1D Joslin Diabetes Center Inc. Rohit Kulkarni Cures 01-June-2022 to 31-December-2025 $494.000,00
GPR75, a novel actor in beta cell regeneration New York Medical College Ercument Dirice Cures 01-April-2022 to 31-March-2026 $750.000,00
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults with Type 1 Diabetes Albert Einstein College of Medicine Jeffrey Gonzalez Improving Lives 01-December-2022 to 30-November-2026 $1.672.180,00